mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0001 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |